FC compared with OPRX: revenue, margins and what each company keeps, and the suppliers and customers both name

FCFranklin Covey Co

Mkt capRevenueRevenue

OPRXOptimizeRx Corp

Mkt capRevenueRevenue

Compare

FCFranklin Covey Co

OPRXOptimizeRx Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±14.9%▼−12.85%×0.86

Q2 FY26±10.0%▲+44.40%×4.44

Jan 8 '26±10.6%▲+0.51%×0.05

Nov 6 '25±25.5%▼−10.07%×0.40

OPRX

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.0%▲+24.72%×1.65

May 13 '26±17.6%▼−22.48%×1.28

= impliedFC realized, solidOPRX realized, hatchedOne scale, both sides: full bar = 45%× = |realized| ÷ impliedSource: market data

Q1 FY26

±18.6%

▼−10.49%

×0.56

Q3 FY25±20.8%▼−17.37%×0.84

FCFranklin Covey Co

18.28▼−0.97%· post 18.28

Mkt cap$204.4MRevenue$68MQ3 FY26Revenue$267MFY25

OPRXOptimizeRx Corp

9.29▼−0.81%· post 9.22

ClosedOct 30 '26

Mkt cap$175.1MRevenue$21MQ2 FY26Revenue$109MFY25

Compare

ClosedOct 30 '26

FCFranklin Covey Co

OPRXOptimizeRx Corp

18.28▼−0.97%post 18.28

Price

9.29▼−0.81%post 9.22

$204.4M

Mkt cap

$175.1M

Q3 FY26$68M

Revenue

$21MQ2 FY26

FY25$267M

Revenue

$109MFY25

FC18.28▼−0.97%vsOPRX9.29▼−0.81%ClosedOct 30 '26